Trial intelligence / Profile preview

PK of Sildenafil in Neonates with PAH

NCT02244528Phase 2Completed

Sponsor
Seoul National University Hospital
Start
Oct 2014
Primary completion
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sildenafil in pulmonary arterial hypertension (PAH), sponsored by Seoul National University Hospital. Started Oct 2014; status: completed.

02

Drugs

sildenafil
03

Conditions

pulmonary arterial hypertension (PAH)

Beyond the preview

Go deeper on NCT02244528.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02244528.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call